Intranasal Therapy

TEL AVIV, Israel — September 14, 2026 Nasus Pharma Ltd. announced that the U.S. Food and Drug Administration (FDA)...

LEIDEN, Netherlands — September 9, 2026 Leyden Laboratories B.V. announced positive Phase 1 results for RIG-101, supporting advancement of...

SARASOTA, Fla., August 10, 2026 Silo Pharma, Inc. announced that the European Patent Office (EPO) has granted a patent...

SOUTH SAN FRANCISCO, Calif., August 6, 2026 Vistagen announced positive topline results from its exploratory Phase 2 repeat-dose clinical...

SARASOTA, Fla., June 29, 2026 Silo Pharma announced that it has initiated a drug-device robustness study for SPC-15, its...

TEL AVIV, Israel, June 9, 2026 Nasus Pharma announced positive results from a preclinical pharmacokinetic (PK) and safety study...